{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-084797","form_type":"8-K","ticker":"MDGL","cik":"0001157601","company_name":"MADRIGAL PHARMACEUTICALS, INC.","filed_at":"2024-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.474585+00:00","generated_at":"2026-06-04T03:20:19.161019+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Madrigal raises ~$86M from underwriters' option exercise; total offering ~$660M","bullets":["Underwriters exercised option to purchase 346,153 shares at $260.00 per share.","Option exercise closed on April 2, 2024; net proceeds of ~$86 million.","Aggregate net proceeds from the offering and option exercise expected ~$660 million.","Offering included 750,000 shares and pre-funded warrants for 1,557,692 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-084797","json":"https://secwatch.observer/filing/0001193125-24-084797.json","markdown":"https://secwatch.observer/filing/0001193125-24-084797.md","text":"https://secwatch.observer/filing/0001193125-24-084797.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1157601/000119312524084797/0001193125-24-084797-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1157601/000119312524084797/d818318d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T03:20:19.161019+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}